ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine
Clinical trial NCT06439628 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06439628
- Sponsor
- Chinese PLA General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-27
- Primary completion
- 2025-09-28
- Enrollment
- 3000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.